Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -61.84% is 122% below its 5-year average of -27.89%, near the high end of its 5-year range (-235.01%–-10.28%).
As of the fiscal period ended Tuesday, June 30, 2026. 49.59% below its 12-month average of -41.34%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -61.84%.
RETURN ON INVESTED CAPITAL (ROIC)
-61.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-41.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-36.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-27.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-49.59%
CURRENT VS 3Y AVG
-71.14%
CURRENT VS 5Y AVG
-121.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 545 covered companies
CURRENT VS SECTOR MEDIAN
-95.56%
vs the sector median at left
LENZ Therapeutics, Inc.
Market Cap
$116.95M
Return on Invested Capital (ROIC)
-61.84%
TTM Avg
-41.34%
3Y Avg
-36.13%
5Y Avg
-27.89%
Market Cap
$118.38M
Return on Invested Capital (ROIC)
-192.18%
TTM Avg
-186.03%
3Y Avg
-161.77%
5Y Avg
-220.86%
Market Cap
$115.06M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-44.27%
3Y Avg
-81.25%
5Y Avg
-78.53%
Market Cap
$118.02M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-74.88%
3Y Avg
-52.32%
5Y Avg
-62.32%
Market Cap
$112.14M
Return on Invested Capital (ROIC)
-44.81%
TTM Avg
-53.33%
3Y Avg
-46.90%
5Y Avg
-39.65%
Market Cap
$114.42M
Return on Invested Capital (ROIC)
-145.10%
TTM Avg
-158.49%
3Y Avg
-239.94%
5Y Avg
-201.97%
Market Cap
$120.28M
Return on Invested Capital (ROIC)
-223.06%
TTM Avg
-221.51%
3Y Avg
-125.15%
5Y Avg
-99.68%
Market Cap
$120.68M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
Market Cap
$111.33M
Return on Invested Capital (ROIC)
-97.99%
TTM Avg
-45.11%
3Y Avg
-60.38%
5Y Avg
-60.38%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | $116.95M | -61.84% | -41.34% | -36.13% | -27.89% |
| Genelux Corporation (GNLX)vs › | $118.38M | -192.18% | -186.03% | -161.77% | -220.86% |
| Coya Therapeutics, Inc. (COYA)vs › | $115.06M | -0.05% | -44.27% | -81.25% | -78.53% |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | -87.72% | -74.88% | -52.32% | -62.32% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $112.14M | -44.81% | -53.33% | -46.90% | -39.65% |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.42M | -145.10% | -158.49% | -239.94% | -201.97% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $120.28M | -223.06% | -221.51% | -125.15% | -99.68% |
| TuHURA Biosciences, Inc. (HURA)vs › | $120.68M | -137.40% | -133.78% | -372.93% | -315.43% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.33M | -97.99% | -45.11% | -60.38% | -60.38% |
| Immunic, Inc. (IMUX)vs › | $110.88M | -92.16% | -430.04% | -259.02% | -188.28% |
ROIC
-61.8%
ROE
-57.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -61.84% |
| 2026-03-31 | -47.96% |
| 2025-12-31 | -32.01% |
| 2025-09-30 | -34.93% |
| 2025-06-30 | -29.94% |
| 2025-03-31 | -30.86% |
| 2024-12-31 | -28.60% |
| 2024-09-30 | -31.61% |
| 2024-06-30 | -38.80% |
| 2024-03-31 | -38.25% |
| 2023-12-31 | -139.66% |
| 2023-09-30 | -75.09% |
| 2023-06-30 | -22.64% |
| 2023-03-31 | -24.99% |
| 2022-12-31 | -235.01% |
| 2022-09-30 | -30.02% |
| 2022-06-30 | -24.89% |
| 2022-03-31 | -20.74% |
| 2021-12-31 | -15.50% |
| 2021-09-30 | -12.16% |
| 2021-06-30 | -10.28% |
| 2021-03-31 | -12.89% |
